Clay Thorp
Founder chez PHASEBIO PHARMACEUTICALS, INC.
Fortune : 56 929 $ au 31/03/2024
Profil
Clay Bernardin Thorp is the founder of PhaseBio Pharmaceuticals, Inc. (founded in 2002) where he holds the title of Chairman.
He is also the founder of Hatteras Venture Partners (founded in 2000) where he holds the title of General Partner.
Mr. Thorp is also the founder of Synthematix, Inc., Karo Bio USA, Inc., and Xanthon, Inc.Mr. Thorp's current job(s) include being the Chairman at Clearside Biomedical, Inc. since 2012, and serving as a Director at GeneCentric Therapeutics, Inc., Rodin Therapeutics, Inc., Curoverse, Inc., Seaport Diagnostics, Inc., and StrideBio, Inc.Mr. Thorp's former job(s) include serving as a Director at CancerGuide Diagnostics, Inc., Device Innovation Group LLC, Pathfinder Therapeutics, Inc., G1 Therapeutics, Inc., and Lysosomal Therapeutics, Inc. He was also an Independent Director at Vigil Neuroscience, Inc. from 2020 to 2022, and an Advisor at Research Triangle Ventures LLC.
Mr. Thorp's education includes a graduate degree from Harvard University in 1994 and an undergraduate degree from The University of North Carolina at Chapel Hill.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 15/04/2023 | 30 522 ( 0,04% ) | 46 699 $ | 31/03/2024 | |
VIGIL NEUROSCIENCE, INC.
0,01% | 31/12/2022 | 3 000 ( 0,01% ) | 10 230 $ | 31/03/2024 |
Postes actifs de Clay Thorp
| Sociétés | Poste | Début |
|---|---|---|
| CLEARSIDE BIOMEDICAL, INC. | Chairman | 01/06/2023 |
| PHASEBIO PHARMACEUTICALS, INC. | Founder | 10/01/2002 |
StrideBio, Inc.
 StrideBio, Inc. BiotechnologyHealth Technology Stridebio, Inc. focuses on creating and developing novel adeno-associated viral vector technologies. The company was founded by Aravind Asokan, Mavis Agbandje-McKenna and Patrick Ritschel and is headquartered in Durham, NC. | Director/Board Member | - |
Rodin Therapeutics, Inc.
 Rodin Therapeutics, Inc. BiotechnologyHealth Technology Rodin Therapeutics, Inc. develops first in class therapeutics for cognitive disorders. The company was founded by Bruce Booth in 2013 and is headquartered in Cambridge, MA. | Director/Board Member | - |
Curoverse, Inc.
 Curoverse, Inc. Packaged SoftwareTechnology Services Curoverse, Inc. develops an open-source platform to manage big genomic data. It develops and maintains open source Internet software for the storage and organization of biomedical and genetic information. The firm offers software distributors, support & training, cluster administration and professional services. The company was founded by Adam F. Berrey, Ward Vandewege, Alexander Wait Zaranek and Jonathan Sheffi in 2010 and is headquartered in Boston, MA. | Director/Board Member | - |
Seaport Diagnostics, Inc.
 Seaport Diagnostics, Inc. BiotechnologyHealth Technology Seaport Diagnostics, Inc. operates as a biotechnology company which develops treatments for genetically inherited diseases. It also offers DNA Tests for consumers across many categories such as nutrition, fitness, behavior tendencies, skincare, and more; provides consumers access to genetic information via mobile application; and manages human cell bank for future testing on regenerative medical therapies. The company was founded by Scott Schaus, Robin Y. Smith and Kate Blanchard on June 30, 2014 and is headquartered in Boston, MA. | Director/Board Member | - |
GeneCentric Therapeutics, Inc.
 GeneCentric Therapeutics, Inc. Medical SpecialtiesHealth Technology GeneCentric Therapeutics, Inc. develops and commercializes molecular diagnostic assays. Its product enables oncologists and patients to make more informed, individualized treatment decisions. The firm's product CSP identifies cancer subtypes that enable drug developers to meet the growing demand for precision medicines, and provide clinicians the information they need to make individualized treatment decisions. The company was founded by David Neil Hayes, Charles M. Perou, and Myla P. Lai-Goldman in 2011 and is headquartered in Durham, NC. | Chairman | - |
Hatteras Venture Partners
 Hatteras Venture Partners Investment ManagersFinance Hatteras Venture Partners (Hatteras Venture) is venture capital firm founded in 2000 by Clay B. Thorp and John Crumpler. The firm is headquartered in Durham, North Carolina. | Founder | 01/01/2000 |
Anciens postes connus de Clay Thorp
| Sociétés | Poste | Fin |
|---|---|---|
| VIGIL NEUROSCIENCE, INC. | Director/Board Member | 09/06/2022 |
| ░░░░░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░ ░░░░ ░░░░ | ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░ | ░░░░░░░ | - |
Formation de Clay Thorp
| Harvard University | Graduate Degree |
| The University of North Carolina at Chapel Hill | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| PHASEBIO PHARMACEUTICALS, INC. | Health Technology |
| CLEARSIDE BIOMEDICAL, INC. | Health Technology |
| G1 THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 15 |
|---|---|
Synthematix, Inc.
 Synthematix, Inc. Packaged SoftwareTechnology Services Synthematix, Inc. develops software to assist in chemistry research. The company is based in Durham, NC. The company was founded by Clay Bernardin Thorp. Synthematix was acquired by Symyx Technologies, Inc. on April 01, 2005 for $17.61 million. | Technology Services |
CancerGuide Diagnostics, Inc.
 CancerGuide Diagnostics, Inc. Medical/Nursing ServicesHealth Services CancerGuide Diagnostics was founded and launched by experienced individuals, passionate about fulfilling the unmet needs in current cancer care and drug development. CancerGuide Diagnostics'™ vision is to dramatically improve the management of cancer by providing physicians with advanced molecular diagnostics that enable individualized treatment decisions. CancerGuide is a singularly focused diagnostic product and services company that is actively licensing high-value, novel technology that may improve the quality of life for those living with cancer. Through its collaboration with Laboratory Corporation of America® Holdings (LabCorp®), CancerGuide provides an innovative development-to-commercial market platform for emerging molecular oncology diagnostic technologies. In addition to its internal diagnostic development programs, CancerGuide provides companion diagnostic development services, including tumor profiling and signature development services, to pharmaceutical and biotechnology companies to help maximize the efficiency and effectiveness of cancer therapy pipelines. | Health Services |
Device Innovation Group LLC
 Device Innovation Group LLC Medical SpecialtiesHealth Technology Device Innovation Group LLC is a health care company. The firm develops early stage medical devices. The company was founded in 2011 and is headquartered in Nashville, TN. | Health Technology |
GeneCentric Therapeutics, Inc.
GeneCentric Therapeutics, Inc. Medical SpecialtiesHealth Technology GeneCentric Therapeutics, Inc. develops and commercializes molecular diagnostic assays. Its product enables oncologists and patients to make more informed, individualized treatment decisions. The firm's product CSP identifies cancer subtypes that enable drug developers to meet the growing demand for precision medicines, and provide clinicians the information they need to make individualized treatment decisions. The company was founded by David Neil Hayes, Charles M. Perou, and Myla P. Lai-Goldman in 2011 and is headquartered in Durham, NC. | Health Technology |
Karo Bio USA, Inc.
 Karo Bio USA, Inc. Miscellaneous Commercial ServicesCommercial Services Karo Bio USA, Inc. develops drug discovery technologies. It develops screening assays and drugs that work upon nuclear receptors. The company is headquartered in Chapel Hill, NC. | Commercial Services |
Xanthon, Inc.
 Xanthon, Inc. Packaged SoftwareTechnology Services Part of Nokia Oyj, Xanthon, Inc. develops enterprise software solutions. The private company is based in Research Triangle Park, NC. The company was founded by Clay Bernardin Thorp. Xanthon was acquired by Talk2 Technology, Inc. on June 14, 1999. | Technology Services |
Research Triangle Ventures LLC
 Research Triangle Ventures LLC Investment ManagersFinance Founded in 2001, Research Triangle Ventures LLC is a seed- and early-stage venture capital fund based in Raleigh, North Carolina. | Finance |
Hatteras Venture Partners
Hatteras Venture Partners Investment ManagersFinance Hatteras Venture Partners (Hatteras Venture) is venture capital firm founded in 2000 by Clay B. Thorp and John Crumpler. The firm is headquartered in Durham, North Carolina. | Finance |
Pathfinder Therapeutics, Inc.
 Pathfinder Therapeutics, Inc. Medical SpecialtiesHealth Technology Pathfinder Therapeutics, Inc. develops computer-assisted surgical navigation products for soft tissue organ surgeries. It provides explorer system that line of sight localization and surface registration techniques to show surgeons where they are in the context of their target organ and surrounding anatomical structures. The firm also offers Scout, a software system for liver surgery planning. The company was founded by William C. Chapman, Benoit M. Dawant, Robert L. Galloway Jr., Alan J. Herline, Michael I. Miga and James D. Stefansic on April 2004 and is headquartered in Nashville, TN. | Health Technology |
Rodin Therapeutics, Inc.
Rodin Therapeutics, Inc. BiotechnologyHealth Technology Rodin Therapeutics, Inc. develops first in class therapeutics for cognitive disorders. The company was founded by Bruce Booth in 2013 and is headquartered in Cambridge, MA. | Health Technology |
Curoverse, Inc.
Curoverse, Inc. Packaged SoftwareTechnology Services Curoverse, Inc. develops an open-source platform to manage big genomic data. It develops and maintains open source Internet software for the storage and organization of biomedical and genetic information. The firm offers software distributors, support & training, cluster administration and professional services. The company was founded by Adam F. Berrey, Ward Vandewege, Alexander Wait Zaranek and Jonathan Sheffi in 2010 and is headquartered in Boston, MA. | Technology Services |
Lysosomal Therapeutics, Inc.
 Lysosomal Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Lysosomal Therapeutics, Inc. engages in the innovation, research, and development in the field of neurodegeneration. It focuses in lysosomal biology in developing novel small molecules for use in the treatment of neurodegenerative diseases. The company was founded by Dimitri Krainc, Joseph Mazzulli, Henri A. Termeer, Robert J. Carpenter, Peter Wirth, Edmund J. Sybertz, and Kees Cornelis Been in 2011 and is headquartered in Cambridge, MA. | Health Technology |
Seaport Diagnostics, Inc.
Seaport Diagnostics, Inc. BiotechnologyHealth Technology Seaport Diagnostics, Inc. operates as a biotechnology company which develops treatments for genetically inherited diseases. It also offers DNA Tests for consumers across many categories such as nutrition, fitness, behavior tendencies, skincare, and more; provides consumers access to genetic information via mobile application; and manages human cell bank for future testing on regenerative medical therapies. The company was founded by Scott Schaus, Robin Y. Smith and Kate Blanchard on June 30, 2014 and is headquartered in Boston, MA. | Health Technology |
StrideBio, Inc.
StrideBio, Inc. BiotechnologyHealth Technology Stridebio, Inc. focuses on creating and developing novel adeno-associated viral vector technologies. The company was founded by Aravind Asokan, Mavis Agbandje-McKenna and Patrick Ritschel and is headquartered in Durham, NC. | Health Technology |
| Vigil Neuroscience, Inc. |
